Question 1

Has Krishna Nayini received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $2,376 in general payments to Krishna Nayini across 149 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Krishna Nayini did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Krishna Nayini come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
Novartis	38	$513
Medtronic(2 entities)	27	$415
Johnson & Johnson	27	$382
Edwards Lifesciences	12	$274
Irhythm Technologies, Inc.	7	$145
Gilead	6	$87
Philips North America LLC	2	$83
Merck	5	$82
Pfizer	5	$79
Amgen	4	$55
E.r. Squibb & Sons, L.L.C.	4	$54
Alnylam Pharmaceuticals Inc.	2	$49
Actelion Pharmaceuticals US, Inc.	2	$35
Amarin Pharma, Inc.	2	$32
Chiesi USA, Inc.	2	$30
Abbott	2	$27
Biotronik Inc.	1	$18
Boehringer Ingelheim	1	$14

Krishna Nayini

Payments from drug & device makers

Who reported the general payments

How this compares

Other interventional cardiology in Longview